China is proposing forward-thinking transplant policies that offer to pay organ donors. These proposals challenge the status quo, however if China is serious about creating an incentive program, transparency and accountability will be vital to its integrity and safety.

Israel should be commended for its two-pronged approach to its organ problem: incentives and efforts to combat trafficking.

Legalizing the sale of organs will correct, not copy, the sins of the organ black market.

We should offer well-informed individuals a reward if they are willing to save a stranger's life.

If we really want to increase the supply of organs, we need to try incentives--financial and otherwise.

Singapore's new law is a positive step toward making the transplant market more transparent.

Left ventricular assist devices, or "heart pumps," are proving to be the best available option for patients with advanced heart failure, and the technology has huge potential for improvement.

Today, nearly 80 percent of active pharmaceutical ingredients originate outside the United States. But the FDA cannot adequately oversee the safety of chemicals manufactured overseas and imported into the United States.